Skip to main content

Table 2 Patient characteristics among studied population

From: Intraoperative hyperglycemia is independently associated with infectious complications after non-cardiac surgery

Co-morbidities

Normoglycemia (Glucose < 8.3 mmol/L)

(N = 1619)

N (%)

Mild hyperglycemia (Glucose 8.3–11.0 mmol/L)

(N = 1042)

N (%)

Moderate hyperglycemia (Glucose 11.1–16.6 mmol/L)

(N = 442)

N (%)

Severe hyperglycemia (Glucose ≥16.7 mmol/L)

(N = 47)

N (%)

Agea

62 ± 15

63 ± 13

61 ± 14

58 ± 15

Body mass index (kg/m2)a

28 ± 8

29 ± 8

30 ± 8

31 ± 9

Male sex

935 (58)

588 (56)

229 (52)

23 (49)

Emergency Operation

136 (8.4)

81 (7.8)

43 (9.7)

8 (17)

Dyspnea (any)

174 (11)

115 (11)

58 (13)

7 (15)

Active Congestive Heart Failure

16 (1.0)

9 (0.9)

5 (1.1)

4 (8.5)

ASAb Physical Status 3 or 4

1168 (72)

767 (74)

332 (75)

40 (85)

Functional Status

(Partially or Totally Dependent)

53 (3.3)

24 (2.3)

12 (2.7)

2 (4.3)

Ascites

19 (1.2)

7 (0.7)

3 (0.7)

1 (2.1)

Diabetes

 Oral Hypoglycemic Treated

153 (9.5)

177 (17)

112 (25)

12 (26)

 Insulin Treated

105 (6.5)

99 (9.5)

86 (20)

21 (45)

COPDc

152 (9.4)

89 (8.5)

25 (5.7)

3 (6.4)

Hypertension

956 (59)

613 (59)

278 (63)

31 (66)

Cardiac disease

365 (23)

208 (20)

86 (20)

13 (28)

Cerebrovascular disease

210 (13)

73 (7.0)

47 (11)

3 (6.4)

Renal Failure or Dialysis

53 (3.3)

10 (1.0)

6 (1.4)

2 (4.3)

Operative duration ≥75th percentile for case-specific national norms

566 (35)

470 (45)

222 (50)

27 (59)

  1. aContinuous parametric data presented as mean ± standard deviation
  2. bASA = American Society of Anesthesiologists
  3. cCOPD = Chronic Obstructive Pulmonary Disease